BRUNO, RAFFAELE
 Distribuzione geografica
Continente #
NA - Nord America 15.153
AS - Asia 9.008
EU - Europa 7.399
SA - Sud America 1.517
Continente sconosciuto - Info sul continente non disponibili 517
AF - Africa 358
OC - Oceania 23
AN - Antartide 1
Totale 33.976
Nazione #
US - Stati Uniti d'America 14.491
CN - Cina 3.605
SG - Singapore 2.189
IT - Italia 1.417
IE - Irlanda 1.309
BR - Brasile 1.152
HK - Hong Kong 1.023
VN - Vietnam 1.008
RU - Federazione Russa 966
DE - Germania 809
FI - Finlandia 612
UA - Ucraina 601
FR - Francia 503
GB - Regno Unito 372
SE - Svezia 294
CA - Canada 273
BD - Bangladesh 234
IN - India 231
ZA - Sudafrica 167
AR - Argentina 123
NL - Olanda 99
MX - Messico 97
IQ - Iraq 84
TR - Turchia 81
JP - Giappone 79
ES - Italia 74
PL - Polonia 71
ID - Indonesia 63
IL - Israele 60
EC - Ecuador 54
PK - Pakistan 54
CR - Costa Rica 51
BE - Belgio 49
VE - Venezuela 48
CO - Colombia 47
SA - Arabia Saudita 37
CZ - Repubblica Ceca 36
HN - Honduras 35
JM - Giamaica 34
SV - El Salvador 34
UZ - Uzbekistan 33
TT - Trinidad e Tobago 32
MA - Marocco 31
PH - Filippine 29
SC - Seychelles 29
TN - Tunisia 29
AT - Austria 28
CL - Cile 26
NI - Nicaragua 26
MY - Malesia 25
LT - Lituania 24
GT - Guatemala 23
CW - ???statistics.table.value.countryCode.CW??? 21
GP - Guadalupe 20
PY - Paraguay 19
AU - Australia 17
CH - Svizzera 17
AZ - Azerbaigian 16
EG - Egitto 16
JO - Giordania 16
KZ - Kazakistan 16
PE - Perù 16
AE - Emirati Arabi Uniti 14
NP - Nepal 14
RO - Romania 14
IR - Iran 13
KE - Kenya 13
UY - Uruguay 13
PR - Porto Rico 12
ET - Etiopia 11
PT - Portogallo 11
AL - Albania 10
BO - Bolivia 10
BY - Bielorussia 10
DZ - Algeria 10
EU - Europa 10
LB - Libano 10
EE - Estonia 9
KG - Kirghizistan 9
SN - Senegal 9
TH - Thailandia 9
MU - Mauritius 8
NG - Nigeria 8
OM - Oman 8
PA - Panama 8
GE - Georgia 7
HU - Ungheria 7
AM - Armenia 6
BG - Bulgaria 6
HR - Croazia 6
KR - Corea 6
LV - Lettonia 6
MD - Moldavia 6
SK - Slovacchia (Repubblica Slovacca) 6
LY - Libia 5
RS - Serbia 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
GY - Guiana 4
LK - Sri Lanka 4
Totale 33.400
Città #
San Jose 1.770
Dublin 1.301
Chandler 1.254
Ashburn 1.185
Singapore 1.105
Hong Kong 991
Council Bluffs 986
Dallas 941
Jacksonville 734
Beijing 662
Nanjing 604
Boardman 476
Los Angeles 372
Ho Chi Minh City 342
Lauterbourg 313
New York 305
Princeton 279
Milan 265
Hanoi 242
Nanchang 237
Lawrence 235
Munich 232
Wilmington 220
Helsinki 216
Shenyang 193
Moscow 183
Hebei 177
Changsha 172
Medford 168
Santa Clara 145
Redondo Beach 144
Johannesburg 139
Buffalo 138
Ann Arbor 137
Shanghai 134
Jiaxing 130
São Paulo 128
Turku 120
Pavia 116
Tianjin 97
Hangzhou 96
Seattle 88
Rome 84
Orem 82
Brooklyn 73
Frankfurt am Main 73
Montreal 72
Tokyo 72
Denver 68
Columbus 64
San Francisco 63
Da Nang 62
Houston 62
Chicago 61
Toronto 60
Chennai 59
Phoenix 57
Falkenstein 56
Warsaw 56
Woodbridge 55
Atlanta 51
Nuremberg 50
Verona 48
Norwalk 47
Brussels 46
The Dalles 46
London 42
North Bergen 42
Turin 42
Haiphong 41
Mexico City 39
Naples 39
Rio de Janeiro 39
Washington 39
San José 36
Stockholm 36
Poplar 35
Pune 34
Guangzhou 33
Brasília 32
San Salvador 32
Amsterdam 31
Fairfield 31
Baghdad 30
Biên Hòa 28
Manchester 28
Tashkent 28
Boston 27
Draper 27
Queens 27
Ankara 25
Belo Horizonte 25
Philadelphia 25
Managua 24
Zhengzhou 24
Newark 23
Curitiba 21
Dhaka 21
Düsseldorf 21
Quito 21
Totale 20.287
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 378
Hepatitis B virus genotype distribution in HIV-1 coinfected patients 263
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 200
AGGRESSIVE INTERFERON THERAPY IN HIV-HCV COINFECTED PATIENTS 178
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 174
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 173
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 172
A mid-term follow-up with a lung ultrasonographic score correlates with the severity of COVID-19 acute phase 171
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 166
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 164
Aggressive daily interferon therapy in HIV-HCV coinfected patients 161
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 160
Hospitalizations Associated With Mental Health Conditions Among Adolescents in the US and France During the COVID-19 Pandemic 159
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 159
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 158
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 153
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 149
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 148
The Pavia consensus statement 142
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 142
Daptomycin Pharmacokinetics and Pharmacodynamics in Patients on Methadone Substitution Therapy 139
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 138
Fungal Osteomyelitis: A Systematic Review of Reported Cases 138
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 137
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: an international multi-centre observational cohort study 136
Consensus conference on TIPS management: Techniques, indications, contraindications 136
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper 136
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 136
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 136
Host factors affecting the outcome of treatment of hepatitis C 134
Mice and rabbits: Animal models for HIV-1 infection 134
Acute liver failure during lamivudine tratment in a hepatitis B cirrhotic patient 132
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 131
Tocilizumab for treatment of severe covid-19 patients: Preliminary results from smatteo covid19 registry (smacore) 131
[New trends in the therapy of cryptococcosis in AIDS patients] 131
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 129
Emerging biological agents for hepatitis C 129
Lung ultrasound presentation of COVID-19 patients: phenotypes and correlations 128
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 128
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 128
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 127
COVID vaccination and asthma exacerbation: might there be a link? 127
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop 126
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 126
AISF position paper on liver disease and pregnancy 126
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 126
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 126
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 126
The early phase of the COVID-19 epidemic in Lombardy, Italy 125
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 125
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 124
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 124
Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy 124
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 123
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. 123
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study 123
A case of leprosy in a nonendemic country 123
Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study 121
A clinical case of sepsis due to staphylococcus pettenkoferi 120
Ventilator-Associated Pneumonia Due to MRSA vs. MSSA: What Should Guide Empiric Therapy? 119
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 119
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol 119
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 119
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 118
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts. 118
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection. 118
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 118
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project 117
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 116
Understanding the Mechanisms of Fibrogenesis in HIV/HCV-Coinfected Patients: Implications for Clinical Practice 116
Challenges for hepatitis C patients coinfected with HIV. 116
High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders 116
Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease 115
Direct-acting Antivirals during or after Immuno-chemotherapy in Hepatitis C Virus-positive Diffuse Large B-cell Lymphomas 115
Management of hepatitis C in human immunodeficiency virus-infected patients 114
Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy 113
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. 112
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 112
Transfusion-transmitted virus infection in HIV-1-seropositive patients 112
Potential pitfalls in the use of real-world data for studying long COVID 111
Can alveolar-arterial difference and lung ultrasound help the clinical decision making in patients with covid-19? 111
Spatial and temporal dynamics of hepatitis B virus d genotype in europe and the mediterranean basin. 111
Area-under-the-curve for peginterferon alpha-2a and peginterferon alpha-2b is not related to body weight in treatment-naive patients with chronic hepatitis C 111
General issues on microbial translocation in HIV-infected patients 111
Cutaneous septic emboli from Candida glabrata in a haematological patient 110
Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a 109
Hepatotoxicity and nelfinavir: a meta-analysis 109
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 109
Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects 109
Prioritization of high-cost new drugs for HCV: making sustainability ethical 109
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy 109
Expression of biomarkers of interferon type I in patients suffering from chronic diseases 108
Ultrasound in the diagnosis of gallbladder ascariasis 108
Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. 108
Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST expert opinion meeting 108
HCV-VIRAL KINETICS IN DIFFERENT CATEGORIES OF PATIENTS: DAILY VERSUS BID INDUCTION INTERFERON THERAPY 107
The role of the rs12979860 polymorphism of the interleukin-28b as a predictor of sustained virological response after antiviral therapy in patients with hemophilia and chronic hepatitis C 107
Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis. 107
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection 107
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders 107
Totale 13.210
Categoria #
all - tutte 153.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.031 0 0 0 0 28 30 23 73 76 18 151 632
2022/20233.645 386 248 40 286 323 368 7 192 1.541 49 145 60
2023/20241.725 173 271 73 88 222 378 91 130 13 64 74 148
2024/20255.349 111 349 103 179 82 238 472 362 1.279 279 599 1.296
2025/202612.930 934 953 1.343 1.468 1.479 548 2.368 557 1.088 990 734 468
2026/20274.045 246 686 778 1.471 864 0 0 0 0 0 0 0
Totale 33.976